Got a run in the fin.
Bell Potter forward estimates create clear picture of PS&C
PUBLISHED: 10 MAR 2015 16:10:33 | UPDATED: 10 MAR 2015 16:38:29
http://www.copyright link/rf/image/2009-2014/AFR/2015/03/10/Photos/b50cb84a-c6e3-11e4-8fc4-4996a27e007f_A67C1038--646x363.jpg
Information and communication technologies business PS&C reported profit 11 per cent below expectations for the half-year.Photo: Louise Kennerley
TREVOR HOEY
Information and communications technology services group PS&C, delivered a mixed result for the six months to December 31, 2014. However, what appears to have stood in the way of investors recognising the quality of the operational performance was the negative earnings impact from investments in its head office, as well as its people and security businesses.
Indicative of this was Bell Potter Securities' observation regarding interim earnings before interest, tax, depreciation and amortisation of $3.5 million which was 5 per cent ahead of its forecasts. Notwithstanding this outperformance, net profit was 11 per cent below the broker's expectations, mainly attributable to slightly higher depreciation, amortisation and interest.
In upgrading forward EBITDA estimates and slightly downgrading earnings-per-share expectations, Bell Potter has factored in these components. The broker maintained its 12-month share price target of $1.20, implying a price-earnings multiple of 10 relative to 2014-15 forecasts. This is well below the industry group average multiple of 14, effectively validating the price target.
PS&C is trading well shy of Bell Potter's 12-month share price target, and at current levels the yield on offer is approximately 7 per cent relative to the broker's 2014-15 forecast dividend of 6 per shar
- Forums
- ASX - By Stock
- Ann: Half Yearly Report and Accounts
Got a run in the fin. Bell Potter forward estimates create clear...
Featured News
Add ASV (ASX) to my watchlist
|
|||||
Last
2.2¢ |
Change
0.002(10.0%) |
Mkt cap ! $14.51M |
Open | High | Low | Value | Volume |
2.0¢ | 2.2¢ | 2.0¢ | $12.05K | 602.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1125788 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 999999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1125788 | 0.019 |
1 | 155666 | 0.018 |
2 | 302844 | 0.016 |
3 | 963889 | 0.014 |
2 | 242000 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 999999 | 1 |
0.023 | 500000 | 1 |
0.024 | 10000 | 1 |
0.026 | 80000 | 1 |
0.029 | 9000 | 1 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
ASV (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online